Chronic Migraine, Headache
Conditions
Keywords
Mesotherapy, Chronic Migraine, pain, muscle, headache
Brief summary
Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain.
Detailed description
Migraine is one of the types of headaches. For the diagnosis of chronic migraine, the headache must last more than 15 days. Nerve blocks, oral medication and neuromodulation are recommended for migraine treatment.Mesotherapy is a type of injection frequently used in clinics. It is a treatment procedure that involves the injection of some drugs under the skin or into the skin. Mesotherapy is used in musculoskeletal system diseases, but it is reported that the effects of its use in migraine are uncertain. This study was planned to show the effectiveness of mesotherapy in patients with migraine.
Interventions
DRUGLidocain
All participants treated with procaine and lidocaine injection for treatment.
Sponsors
Kanuni Sultan Suleyman Training and Research Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Masking description
open label
Intervention model description
Retrospective analysis of the group that received treatment
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
\- Clinical diagnosis of chronic migraine disease
Exclusion criteria
* Infection disease * Thyroid disease * Anemia disease * Systemic disease
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analog Scale (VAS) | Baseline | VAS rates pain on a scale of zero to 10. It is explained to the participant that 10 points means unbearable pain, zero points means no pain, and the patient is asked to rate his pain between zero and ten. Higher scores indicate increased pain severity |
| The frequency of painful days per month | Baseline | The participant is asked how many days she/he feels pain in a month.Higher numbers indicate increased frequency of painful days |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Duration of attack per month | Baseline | The participant is questioned about how long each attack lasts within a month. Increased periods indicate prolonged symptom duration. |
| the number of analgesic per month | Baseline | The participant is asked how many times he/she uses analgesic medication in a month. Higher numbers indicate an increased need for medical treatment |
Countries
Turkey (Türkiye)
Outcome results
None listed